Contract Manufacturing

Baxter (NYSE:BAX) is planning on spending $50 million to expand a sterile fill/finish manufacturing facility in Bloomington, Ind.  Baxter’s BioPharma Solutions business will manage the site, including a new 25,000-ft2 warehouse, a new filling line for flexible plastic containers and a high-speed automated syringe fill line.  Baxter hopes to wrap up manufacturing at the site in…

Transitioning from traditional batch to continuous manufacturing provides greater throughput, but it requires near real-time data analysis to proactively address potential problems. Continuous manufacturing (CM) is gaining popularity in the pharmaceutical industry because it represents an improved approach for small molecule drug product development compared to traditional batch manufacturing methods. CM allows for the production…

Vibalogics announced that it initiated the first phase of its planned $150 million investment in a virotherapy facility near Boston. The global contract development and manufacturing organization (CDMO) has a three-year investment plan which includes building a 110,000 square-foot facility, with the $150 million covering redevelopment, equipment and personnel, according to a news release. Get the…

Thermo Fisher Scientific Inc. (NYSE:TMO) and Innoforce have agreed to set up a new pharma services facility in Hangzhou, China for biologics and drug development and manufacturing.  Innoforce is a Hangzhou, China-based contract development and manufacturing company. The two companies expect to complete the facility in 2022.   The site will become part of Thermo Fisher’s…

Chemical company Avantor (NYSE:AVTR) recently said it expects to achieve sales growth of 5.4% in its third fiscal quarter of 2020, with biopharma and healthcare businesses driving quarterly revenues of $1.6 billion. Avantor offers a range of ultra-high-purity materials to biopharma companies. This year, the company also created a COVID-19 division to support virus detection, therapy…

As Pfizer and its German biotech partner BioNTech progress with a Phase 3 COVID-19 vaccine candidate, the companies are preparing for the prospect of delivering an approved vaccine at scale. Pfizer anticipates that it could produce up to 100 million doses in the remainder of 2020 and an additional 1.3 billion next year. The companies…

Aphena Pharma Solutions recently announced that it is spending $21 million to expand its Solid Dose Division in Cookeville, Tenn Aphena Pharma has purchased a 500,000 ft2 property, purpose-built for FDA manufacturing and packaging operations. Renovations have already started to turn the site into a state-of-the-art pharmaceutical packaging and distribution facility that will also serve…

The Trump administration today released a plan to distribute an eventual COVID-19 vaccine free of charge, initially to targeted groups and more broadly as supply increases. The government is planning a phased distribution using a contract awarded to McKesson in August. The first recipients could include: Healthcare personnel likely to be exposed to or treat people…

Inovio Pharmaceuticals (NSDQ:INO) announced that Thermo Fisher Scientific (NYSE:TMO) will manufacture its COVID-19 vaccine candidate. Plymouth Meeting, Pa.-based Inovio said in a news release yesterday that Thermo Fisher signed a letter of intent to manufacture the INO-4800 COVID-19 vaccine candidate, joining a consortium of third-party manufacturers that aim to produce 100 million doses of Inovio’s vaccine by 2021,…

Specialty glass manufacturer Schott announced today that it is delivering vials to three out of every four COVID-19 vaccine projects undergoing phase I, II, and III testing , according to Global Data. The Mainz, Germany-based company has delivered millions of glass vials to SARS-CoV-2 programs, including partners of the Trump administration’s Operation Warp Speed vaccine…